Global Veterinary CRO and CDMO Market Size & Trends Report Segmented by Product (Small Molecules, Biologics, Nutraceuticals, Medical Devices), Animal Type (Companion, Livestock), Therapeutic Area (Infections, Oncology), Phase (Pre-clinical, Clinical, Commercial) Regional Forecast to 2030
The global veterinary CRO and CDMO market is set to witness a growth rate of 9% in the next 5 years. Rapid growth in companion-animal healthcare spending, rise of complex modalities, growing pressure to shorten time-to-market & control R&D costs, and growing consolidation & preference for platform service models, are some of the key factors driving the veterinary CRO and CDMO market. To learn more about the research report, download a sample report.
Overview
Veterinary contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) offer a unique service model that aids animal health organizations in the development, testing, and ultimately manufacture of veterinary medicines, vaccines, and biologics among others. CROs are responsible for research elements, e.g., preclinical studies, safety studies, clinical trials and ensuring regulatory compliance; while a CDMO supports the formulation, process and product development, scale-up, and GMP manufacturing. Veterinary CROs and CDMOs support animal health companies in overcoming issues pertaining to expertise, infrastructure, and cost showing an overall benefit through shortened time to market and allowing animal health companies to focus on their core strategic goals.
To learn more about this report, download the PDF brochure
Rapid growth in companion-animal healthcare spending to drive market growth
The veterinary CRO and CDMO market is heavily influenced by the surge in companion-animal healthcare spending because pet owners are increasingly looking for more advanced therapies (biologics, oncology and specialty medicines). In the US alone, total expenditure on pets (i.e., pet industry) increased substantially by c.46% between 2020-2024e. Expenditure on pet health & products increased c.25% between 2020-2024e (Source: APPA). As disposable incomes rise, and emotional bonds between pets and their owners strengthen, consumers are more willing to spend money for the absolute best care for their companion animals. This requires animal health companies to build pipelines and to leverage outsourcing services (to CROs and CDMOs) for preclinical studies, research and development, clinical testing for new molecular entities, and manufacturing. All this bodes well for faster times to market, increased services needed, and continued growth in the market at a global level.
To learn more about this report, download the PDF brochure
Growing consolidation & preference for platform service to boost market growth
Increasing consolidation & preference for platform services is driving growth in the veterinary CRO and CDMO markets by offering integrated, end-to-end solutions that more effectively facilitate the development and manufacture of products. Instead of working with multiple organizations with distinct services, animal health clients increasingly prefer to partner with service providers that can offer everything from discovery and toxicology to clinical trials and regulatory and commercial-scale production under one umbrella. This reduces the complexity of managing various timelines, expands potential efficiencies, and improves cost effectiveness. Consolidation through M&A also expands global reach and capabilities, enabling service providers to offer comprehensive platforms that attract more clients and drive sustained market expansion.
Competitive Landscape Analysis
The global veterinary CRO and CDMO market is marked by the presence of established and emerging market players such as Charles River Laboratories; Clinglobal; Argenta Holdco Limited; knoell Germany GmbH; OCRvet; Veterinary Research Management; VETSPIN SRL; Vetio; TriRx Pharmaceutical Services; and Tekrolab; among others. Some of the key strategies adopted by market players include new service launch, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| Growth Rate | 9% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | By Product, Animal Type, Therapeutic Area, Phase, End User |
| Regional Scope |
|
| Key Companies Mapped | Charles River Laboratories; Clinglobal; Argenta Holdco Limited; knoell Germany GmbH; OCRvet; Veterinary Research Management; VETSPIN SRL; Vetio; TriRx Pharmaceutical Services; and Tekrolab among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Â
Global Veterinary CRO and CDMO Market Segmentation
This report by Medi-Tech Insights provides the size of the global veterinary CRO and CDMO market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, animal type, therapeutic area, phase, and end user.
Market Size & Forecast (2023-2030), By Product, USD Million
- Small Molecules
- Biologics
- Nutraceuticals and Feed Additives
- Medical Devices
Market Size & Forecast (2023-2030), By Animal Type, USD Million
- Companion Animals
- Livestock Animals
Market Size & Forecast (2023-2030), By Therapeutic Area, USD Million
- Infectious Diseases
- Oncology
- Dermatology
- Pain & Inflammation Management
- Metabolic Disorders
- Others
Market Size & Forecast (2023-2030), By Phase, USD Million
- Pre-clinical
- Clinical
- Commercial
Market Size & Forecast (2023-2030), By End User, USD Million
- Veterinary Pharmaceutical and Biopharmaceutical Companies
- Veterinary Medical Device Companies
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the veterinary CRO and CDMO market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the veterinary CRO and CDMO market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Related Reports
- Veterinary Ultrasound Market – Global Industry Analysis, Size, Share, Growth & Revenue for Forecast 2024 to 2029
- Global Veterinary Imaging Market Size & Trends Report Segmented by Product (X-ray, Ultrasound), Solutions (Equipment, Accessories /Consumables, PACS), Animal Type (Large, Small), Application (Orthopedic, Oncology, Cardiology), & Regional Forecast to 2030
- Global Veterinary Diagnostics Market Size & Trends Report Segmented by Product (Consumables, Instruments), Test Type (Clinical Chemistry, Microbiology, Others), Animal Type (Production, Companion), End-user (Veterinary Hospitals & Clinics) Analysis & Regional Forecasts to 2030
- Introduction
- Introduction​
- Market Scope​
- Market Definition​
- Segments Covered​
- Regional Segmentation​
- Research Timeframe​
- Currency Considered​
- Study Limitations​
- Stakeholders​
- List of Abbreviations​
- Key Conferences and Events (2025-2026)​
- Research Methodology​
- Secondary Research​
- Primary Research​
- Market Estimation​
- Bottom-Up Approach​
- Top-Down Approach​
- Market Forecasting​
- Executive Summary
- Veterinary CRO and CDMO Market Snapshot (2025-2030)​
- Segment Overview​
- Regional Snapshot​
- Competitive Insights ​
- Market Overview
- Market Dynamics
- Drivers
- Rapid growth in companion-animal healthcare spending
- Rise of complex modalities
- Growing pressure to shorten time-to-market & control R&D costs
- Growing consolidation & preference for platform service models
- Restraints​
- Fragmented, and regionally variable regulatory frameworks
- Capacity constraints and limited skilled workforce
- Logistics and supply-chain complexity for biologics and cold-chain
- Opportunities​
- Biologics, monoclonal antibodies and novel vaccines
- Geographic expansion and local manufacturing in emerging markets
- Platform and verticalized/end-to-end service offerings
- Data services and real-world evidence
- Key Market Trends​
- Digitalization of veterinary trials
- Greater attention on zoonotic diseases
- Capacity build-outs for sterile/biologics manufacturing
- Unmet Market Needs​
- Industry Speaks​
- Drivers
- Market Dynamics
- Global Veterinary CRO and CDMO Market Size & Forecast (2023-2030), By Product, USD Million
- Introduction​
- Small Molecules
- Biologics
- Nutraceuticals and Feed Additives
- Medical Devices
- Global Veterinary CRO and CDMO Market Size & Forecast (2023-2030), By Animal Type, USD Million
- Introduction​
- Companion Animals
- Livestock Animals
- Global Veterinary CRO and CDMO Market Size & Forecast (2023-2030), By Therapeutic Area, USD Million
- Introduction​
- Infectious Diseases
- Oncology
- Dermatology
- Pain & Inflammation Management
- Metabolic Disorders
- Others
- Global Veterinary CRO and CDMO Market Size & Forecast (2023-2030), By Phase, USD Million
- Introduction​
- Pre-clinical
- Clinical
- Commercial
- Global Veterinary CRO and CDMO Market Size & Forecast (2023-2030), By End User, USD Million​
- Introduction
- Veterinary Pharmaceutical and Biopharmaceutical Companies
- Veterinary Medical Device Companies
- Others
- Global Veterinary CRO and CDMO Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction​
- North America Veterinary CRO and CDMO Market Size & Forecast (2023-2030), By Country, USD Million​
- US​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Animal Type (USD Million)​
- Market Size & Forecast, By Therapeutic Area (USD Million)​
- Market Size & Forecast, By Phase (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Canada​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Animal Type (USD Million)​
- Market Size & Forecast, By Therapeutic Area (USD Million)​
- Market Size & Forecast, By Phase (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- US​
- Europe Veterinary CRO and CDMO Market Size & Forecast (2023-2030), By Country, USD Million​
- UK ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Animal Type (USD Million)​
- Market Size & Forecast, By Therapeutic Area (USD Million)​
- Market Size & Forecast, By Phase (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Germany ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Animal Type (USD Million)​
- Market Size & Forecast, By Therapeutic Area (USD Million)​
- Market Size & Forecast, By Phase (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- France ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Animal Type (USD Million)​
- Market Size & Forecast, By Therapeutic Area (USD Million)​
- Market Size & Forecast, By Phase (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Italy ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Animal Type (USD Million)​
- Market Size & Forecast, By Therapeutic Area (USD Million)​
- Market Size & Forecast, By Phase (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Spain ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Animal Type (USD Million)​
- Market Size & Forecast, By Therapeutic Area (USD Million)​
- Market Size & Forecast, By Phase (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Rest of Europe ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Animal Type (USD Million)​
- Market Size & Forecast, By Therapeutic Area (USD Million)​
- Market Size & Forecast, By Phase (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- UK ​
- Asia Pacific (APAC) Veterinary CRO and CDMO Market Size & Forecast (2023-2030), By Country, USD Million​
- China ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Animal Type (USD Million)​
- Market Size & Forecast, By Therapeutic Area (USD Million)​
- Market Size & Forecast, By Phase (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Japan ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Animal Type (USD Million)​
- Market Size & Forecast, By Therapeutic Area (USD Million)​
- Market Size & Forecast, By Phase (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- India ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Animal Type (USD Million)​
- Market Size & Forecast, By Therapeutic Area (USD Million)​
- Market Size & Forecast, By Phase (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Rest of Asia Pacific ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Animal Type (USD Million)​
- Market Size & Forecast, By Therapeutic Area (USD Million)​
- Market Size & Forecast, By Phase (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- China ​
- Latin America (LATAM) Veterinary CRO and CDMO Market Size & Forecast (2023-2030), USD Million​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Animal Type (USD Million)​
- Market Size & Forecast, By Therapeutic Area (USD Million)​
- Market Size & Forecast, By Phase (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Middle East & Africa (MEA) Veterinary CRO and CDMO Market Size & Forecast (2023-2030), USD Million​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Animal Type (USD Million)​
- Market Size & Forecast, By Therapeutic Area (USD Million)​
- Market Size & Forecast, By Phase (USD Million)​
- Market Size & Forecast, By End User (USD Million)​
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Solutions/Services Offered, Recent Developments)
- Charles River Laboratories
- Clinglobal
- Argenta Holdco Limited
- knoell Germany GmbH
- OCRvet
- Veterinary Research Management
- VETSPIN SRL
- Vetio
- TriRx Pharmaceutical Services
- Tekrolab
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Veterinary Pharmaceutical and Biopharmaceutical Companies; Veterinary Medical Device Companies; and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
Features of the Report
- Comprehensive Market Coverage
- Market Size and Forecast
- Geographic & Segment Deep Dives
- Strategic Insights & Competitive Landscape
- Timely & Updated Data
- Growth Indicators & Future Outlook
- Quick Turnaround on Queries
- Analyst Support
- Report Customization Available
- Reports in PDF & Excel
